Press & Media

AI-Driven Tool Links Lung Fibrosis to Accelerated Aging in IPF and Aging Research    
Read
AI-designed drug shows promise for inflammatory bowel disease  
Read
Generative AI designs drug for inflammatory bowel disease treatment  
Read
Carbon Biosciences Announces New Appointments to Board of Directors and Scientific Advisory Board
Read
Insilico Medicine appoints Carol Satler, MD., PhD, as Vice President of Clinical Development to advance non-oncology programs  
Read
Insilico Medicine Appoints Carol Satler as VP of Clinical Development to Advance Non-Oncology Programs
Read
Sobi Names Carol Satler, M.D., Ph.D., Vice President, Medical Affairs, North America
Read

Coming Soon

Read

Coming Soon

Read

Research

Recent advances in the Laboratory of Molecular and Cellular Cardiology
Read
Novel missense mutation in the cyclic nucleotide-binding domain of HERG causes long QT syndrome
Read
Measuring Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Not on Active Treatment (MOTION): A Study of the Effects of Riociguat on Patient-Reported Outcomes and an Exploration of Telemetric Technology in PAH  
Read
Contact Carol